Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Regions Financial: One of the Best Banking Bets

Page 1 of 2

Regions Financial Corporation (NYSE:RF) has been steadily outperforming its major peers, up 65% year to date, whereas BB&T, Huntington, Fifth Third and PNC are all up less than 20%. When comparing Regions to larger banks like JPMorgan and Wells Fargo, the latter two have returned less than half that of RF shares. Billionaire Jim Simons is one of Regions’ biggest fans after he increased his stake by almost 250% last quarter (check out Jim Simons’ biggest bets).


With robust initiatives to de-risk its portfolio through asset liquidation and a reduction in real estate, Regions has managed to lower its debt-to-capital ratio to an industry-low 35%. Regions has also seen positive votes of confidence from all of the major rating agencies. S&P upped its outlook to stable in August 2011, Fitch Ratings moved Regions to stable in November of that same year, and Moody’s gave the bank this designation in February 2012.

On the revenue side, net top line is expected to be down 17% by the end of this year as brokerage and investment banking sales decline, but this negative growth is expected to slow in 2013 to -3.5%. Regions also collected $1.2 billion on the sale of its brokerage unit, Morgan Keegan, to Raymond James Financial. This boost in cash position could help improve Regions’ dividend yield of 0.6%.

Regions trades well below major peer Fifth Third at a P/B of 0.7x, which is also below the other major banks. We believe that Regions is in part shunned due to its 16x trailing P/E; this is unattractive compared to Fifth Third (10x) and Wells Fargo (11x). Looking at its forward P/E of only 9x, though, we see solid value where investors might be overlooking Regions’ growth potential.

Is it a better investment, though, than its competitors?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!